| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |